ASR Vermogensbeheer’s Pfizer PFE Stock Holding History

ASR Vermogensbeheer’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.4M	Buy	845,613 +230,740	+38%	+$6.04M	0.21%	105
2026 Q1	$17.3M	Buy	614,873 +12,729	+2%	+$339K	0.2%	108
2025 Q4	$15M	Sell	602,144 -5,122	-0.8%	-$129K	0.17%	118
2025 Q3	$15.5M	Sell	607,266 -2,131	-0.3%	-$52.6K	0.19%	108
2025 Q2	$14.8M	Buy	609,397 +11,443	+2%	+$267K	0.19%	108
2025 Q1	$15.2M	Buy	+597,954	New	+$15.6M	0.22%	100

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ASR Vermogensbeheer's PFE Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Pfizer (PFE) stake by 38% in Q2 2026, buying an estimated $6.04M and bringing the position to 845,613 shares worth $20.4M. The position accounts for 0.21% of the portfolio, ranked #105.

ASR Vermogensbeheer first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

ASR Vermogensbeheer held 845,613 shares of Pfizer worth $20.4M as of Q2 2026.
ASR Vermogensbeheer bought 230,740 Pfizer shares in Q2 2026, an estimated $6.04M.
Pfizer made up 0.21% of ASR Vermogensbeheer's portfolio in Q2 2026, its #105 holding.
ASR Vermogensbeheer first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.